Besides this, patients taking antiplatelet drugs and anticoagulants who develop thrombocytopenia due to the VEGFR-targeted TKIs might be at further increased risk of bleeding, and those with a history of inflammatory bowel disease or diverticulitis should be monitored carefully for gastrointestinal bleeding. This evidence concerns the gene KDR and Thrombocytopenia.